- Home
- ZURA vs REFI Comparison
ZURA vs REFI Comparison
Compare ZURA & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | REFI |
|---|---|---|
| Founded | 2022 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 255.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZURA | REFI |
|---|---|---|
| Price | $4.45 | $12.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $11.38 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 439.9K | 121.1K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 16.04% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $54,287,847.00 |
| Revenue This Year | N/A | $13.78 |
| Revenue Next Year | N/A | $4.07 |
| P/E Ratio | ★ N/A | $7.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.97 | $11.85 |
| 52 Week High | $4.68 | $16.29 |
Technical Indicators
Market Signals| Indicator | ZURA | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 66.32 | 51.81 |
| Support Level | $4.00 | $12.76 |
| Resistance Level | $4.44 | $13.25 |
| Average True Range (ATR) | 0.24 | 0.28 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 95.31 | 39.33 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.